| A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG (NCT03330197) | Alaunos Therapeutics | 2017-09-26 |
| Venetoclax and Ibrutinib in Patients With Relapsed/Refractory CLL or SLL (NCT03045328) | Steven E. Coutre | 2017-09-26 |
| The Efficacy and Safety of K-001 in the Treatment of Advanced Pancreatic Cancer (NCT04183478) | RenJi Hospital | 2017-09-26 |
| INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers (NCT02989662) | Johns Hopkins University | 2017-09-26 |
| A Study to Investigate the Stain and Plaque Removal Capability of Two Experimental Potassium Nitrate Dentifrices (NCT03267511) | GlaxoSmithKline | 2017-09-25 |
| Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Myeloid Leukemia (NCT03118466) | Massachusetts General Hospital | 2017-09-25 |
| Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc) (NCT03274076) | University of Michigan | 2017-09-25 |
| Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment (NCT03326505) | University of Jordan | 2017-09-25 |
| Hallmarks of Protective Immunity in Sequential Rhinovirus Infections in Humans (NCT02796001) | University of Virginia | 2017-09-25 |
| CHOCOlate MeLatonin for AdolescenT MigrainE (NCT03597529) | Amy Gelfand | 2017-09-25 |
| A Study to Evaluate the Safety and Efficacy of ATx201 in Subjects With Moderate Atopic Dermatitis (NCT03304470) | UNION therapeutics | 2017-09-25 |
| 4SC-202 in Combination With Pembrolizumab in Patients Primary Refractory/Non-responding to Prior Anti-PD-1 Therapy (NCT03278665) | 4SC AG | 2017-09-25 |
| Study to Treat Major Depressive Disorder With a New Medication (NCT03043560) | James Murrough | 2017-09-25 |
| Novel Compositions for Treating or Preventing Dermal Disorders (NCT03103893) | Drexel University | 2017-09-25 |
| A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma (NCT03290950) | Memorial Sloan Kettering Cancer Center | 2017-09-25 |
| Study of Paclitaxel, Carboplatin, and PF-05212384 in Advanced or Metastatic NSCLC (UF-STO-LUNG-002) (NCT02920450) | University of Florida | 2017-09-25 |
| Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease (NCT03414541) | Afimmune | 2017-09-24 |
| Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis (NCT03265613) | Guangdong Provincial Hospital of Traditional Chinese Medicine | 2017-09-24 |
| Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma (NCT03127774) | Columbia University | 2017-09-22 |
| The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity (NCT03119610) | Sara Espinoza | 2017-09-22 |
| A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa. (NCT03248531) | UCB Biopharma SRL | 2017-09-22 |
| Predictive Value of Drug Sensitivity Testing Tumorspheres From Patients With Metastatic Colorectal Cancer (NCT03251612) | Vejle Hospital | 2017-09-22 |
| A Study Evaluating ClariVein With a Sclerosing Agent for the Treatment of Venous Insufficiency (NCT03311269) | Vascular Insights, LLC | 2017-09-22 |
| A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) (NCT03178552) | Hoffmann-La Roche | 2017-09-22 |
| Transversalis Fascia Plane Blocks for Analgesia Post-cesarean Delivery (NCT03236324) | University of Calgary | 2017-09-22 |
| Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT03204188) | National Heart, Lung, and Blood Institute (NHLBI) | 2017-09-22 |
| Phase 2 Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer (NCT03291886) | Kyowa Kirin Co., Ltd. | 2017-09-22 |
| The Effectiveness of tDCS on Internet Game Addiction (NCT03347643) | Seoul National University Hospital | 2017-09-22 |
| Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM) (NCT03018288) | National Cancer Institute (NCI) | 2017-09-21 |
| Rituximab Objective Outcome Measures Trial in SLE (NCT03054259) | University of Leeds | 2017-09-21 |
| Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients (NCT03190941) | National Cancer Institute (NCI) | 2017-09-21 |
| An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus (NCT03252587) | Bristol-Myers Squibb | 2017-09-21 |
| Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis, Living With or Without HIV (NCT02906007) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-09-21 |
| FactOr XIa inhibiTion for the pRevention of venOus Thromboembolism in Patients Undergoing Total Knee Arthroplasty (NCT03276143) | Bayer | 2017-09-21 |
| Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer (NCT02955394) | University of Colorado, Denver | 2017-09-21 |
| FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma (NCT03283761) | Al B. Benson, III, MD | 2017-09-21 |
| Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy (NCT03354338) | Universidad El Bosque, Bogotá | 2017-09-21 |
| Brentuximab Vedotin for Systemic Sclerosis (NCT03222492) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-09-20 |
| Modification of Extracorporeal Photopheresis in Cutaneous T-cell Lymphoma or Chronic Graft-versus-host Disease (NCT03109353) | St. Olavs Hospital | 2017-09-20 |
| A Study to Evaluate the Efficacy and Safety of VX-150 in Treating Subjects With Pain Caused by Small Fiber Neuropathy (NCT03304522) | Vertex Pharmaceuticals Incorporated | 2017-09-20 |
| Study of TBI-1301 (NY-ESO-1 T Cell Receptor Gene Transduced Autologous T Lymphocytes) in Patients with Synovial Sarcoma (NCT03250325) | Takara Bio Inc. | 2017-09-20 |
| Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication (NCT03194776) | Novartis Pharmaceuticals | 2017-09-20 |
| P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM) (NCT03288493) | Poseida Therapeutics, Inc. | 2017-09-20 |
| The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome (NCT04422327) | PrecisionBiotics Group Ltd. | 2017-09-20 |
| Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer (NCT03284957) | Sanofi | 2017-09-20 |
| Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma (NCT03137888) | Emory University | 2017-09-20 |
| Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses (NCT03185871) | University of Wisconsin, Madison | 2017-09-20 |
| Panblok H7 Vaccine Adjuvanted With AS03 or MF59 (NCT03283319) | Biomedical Advanced Research and Development Authority | 2017-09-20 |
| Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE) (NCT03767348) | Replimune, Inc. | 2017-09-20 |
| A Study of an Investigational Drug, Cemdisiran (ALN-CC5), in Patients With Atypical Hemolytic Uremic Syndrome (NCT03303313) | Alnylam Pharmaceuticals | 2017-09-19 |
| Durvalumab (MEDI4736) and Tremelimumab in Hormone Receptor-positive, Hypermutated Metastatic Breast Cancer Identified by Whole Exome Sequencing (NCT03608865) | Yonsei University | 2017-09-19 |
| Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia (NCT03255629) | Joslin Diabetes Center | 2017-09-19 |
| Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS) (NCT03288870) | Biocad | 2017-09-19 |
| Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients (NCT02927366) | Novartis Pharmaceuticals | 2017-09-19 |
| Bortezomib/Dexamethasone Therapy in Patients With Relapsed and/or Refractory Cutaneous T-cell Lymphoma (NCT03487133) | Samsung Medical Center | 2017-09-19 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Proof of Mechanism of GSK2618960 in Primary Sjögren's Syndrome (pSS) (NCT03239600) | GlaxoSmithKline | 2017-09-19 |
| Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma (NCT03262389) | Michael C Roarke, MD | 2017-09-19 |
| Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis (NCT03290248) | AOBiome LLC | 2017-09-19 |
| A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors (NCT03267316) | Cantargia AB | 2017-09-19 |
| IP ALT-803 Followed by SQ ALT-803 for Ovarian Cancer (NCT03054909) | Masonic Cancer Center, University of Minnesota | 2017-09-19 |
| Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus (NCT03117998) | REMD Biotherapeutics, Inc. | 2017-09-19 |
| A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated. (NCT03238963) | Boehringer Ingelheim | 2017-09-19 |
| Rapamycin Treatment for ALS (NCT03359538) | Azienda Ospedaliero-Universitaria di Modena | 2017-09-19 |
| IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients (NCT03203005) | National Cancer Institute, Naples | 2017-09-18 |
| CD19-targeting, 3rd Generation CAR T Cells for Refractory B Cells Malignancy (NCT03068416) | Uppsala University | 2017-09-18 |
| Molecular Imaging of Inflammation With 18F-PBR06 to Identify Unstable Carotid Plaques in Patients With Stroke (NCT02513589) | University Hospital, Bordeaux | 2017-09-18 |
| Vitamin C in Atrial Fibrillation Ablation (NCT03148236) | Virginia Commonwealth University | 2017-09-18 |
| Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist (NCT03218969) | William Ondo, MD | 2017-09-18 |
| A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer (NCT03258398) | Effector Therapeutics | 2017-09-18 |
| Naloxone, Hypoglycemia and Exercise (NCT03149770) | University of Minnesota | 2017-09-18 |
| Single-ascending-dose Study of the Safety and Immunogenicity of NasoVAX (NCT03232567) | Altimmune, Inc. | 2017-09-18 |
| Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer (NCT02892734) | Northwestern University | 2017-09-18 |
| Efficacy and Safety of Dexamethasone Nanoparticles Eye Drops in Diabetic Macular Edema (NCT05343156) | Oculis | 2017-09-18 |
| A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors (NCT03257631) | Celgene | 2017-09-18 |
| Safety and Efficacy of Propranolol in the Treatment of Tardive Dyskinesia (NCT03254186) | Emory University | 2017-09-18 |
| 99mTc-rhAnnexin V-128 in Diagnosis of Spondyloarthritis (NCT03232580) | Advanced Accelerator Applications | 2017-09-18 |
| Evaluation of the Safety and Immunogenicity of a Recombinant Trivalent Nanoparticle Influenza Vaccine With Matrix M-1 Adjuvant (NanoFlu) (NCT03293498) | Novavax | 2017-09-18 |
| A Single-dose Trial to Investigate the Safety and Tolerability of XEN-D0501 in Patients With Diabetes Mellitus Type 2 (NCT03278158) | Pila Pharma | 2017-09-18 |
| Phase IIb Study of Evobrutinib in Subjects With Rheumatoid Arthritis (NCT03233230) | EMD Serono Research & Development Institute, Inc. | 2017-09-18 |
| Triple Antimalarial Combination to Accelerate the Parasite Clearance and to Prevent the Selection of Resistant Parasites (NCT03697668) | Nurex S.r.l. | 2017-09-17 |
| Identification of Compound Isolated From Cock's Comb and Its Effect on Arsenical Palmar Keratosis (NCT03635853) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2017-09-16 |
| Identification of Compound From Brinjal Peel Extract in the Treatment of Palmar Arsenical Keratosis and Bowen's Disease (NCT03641079) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2017-09-16 |
| Evaluation of Oncoxin-Viusid® in Prostate Cancer (NCT03543670) | Catalysis SL | 2017-09-16 |
| Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC) (NCT03285321) | Greg Durm, MD | 2017-09-15 |
| Gene Therapy for Beta-Thalassemia Major Using Autologous Hematopoietic Stem Cell Genetically Modified (NCT03276455) | Nanfang Hospital, Southern Medical University | 2017-09-15 |
| A Study of Everolimus Plus Exemestane in Chinese Postmenopausal Women With Estrogen Receptor Positive, Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Non-steroidal Aromatase Inhibitor (NCT03312738) | Novartis Pharmaceuticals | 2017-09-15 |
| Intrawound Vancomycin Prophylaxis for Neural Stimulator (NCT03221023) | University of British Columbia | 2017-09-15 |
| MAPS & ITEC Cohorts: 6-8 Years Follow-up (NCT03763630) | University of Southampton | 2017-09-15 |
| Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Patients ≥65 Years (NCT03233217) | Sanofi Pasteur, a Sanofi Company | 2017-09-15 |
| Effect of Topical Sulforaphane on Skin Fragility Seen in Skin Aging and With Ultraviolet Exposure (NCT03126539) | Johns Hopkins University | 2017-09-15 |
| Lidocaine for Oxaliplatin-induced Neuropathy (NCT03254394) | Washington University School of Medicine | 2017-09-15 |
| Based on the Ultrasound Evaluating the Effect of Xiaozhong Fang Particles for Knee Osteoarthritic With Synovial Fluid (NCT03586700) | Beijing University of Chinese Medicine | 2017-09-15 |
| Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients (NCT03251963) | University of Utah | 2017-09-15 |
| Prospective Randomized Controlled Trial for Prevention of Demineralization During Fixed Orthodontic Treatment (NCT04342858) | The University of Hong Kong | 2017-09-15 |
| Pembrolizumab and Exemestane/ Leuprolide in Premenopausal HR+/ HER2- Locally Advanced or Metastatic Breast Cancer (NCT02990845) | National Taiwan University Hospital | 2017-09-15 |
| Novel Autologou CAR-T Therapy for Relapsed/Refractory B Cell Lymphoma (NCT03258047) | First Affiliated Hospital of Zhejiang University | 2017-09-15 |
| High Dosage Buprenorphine as a Drug Strategy Withdrawal Assistance of Analgesics Opioid (NCT03156907) | University Hospital, Clermont-Ferrand | 2017-09-15 |
| Ixazomib for Desensitization (NCT03213158) | University of Wisconsin, Madison | 2017-09-15 |
| DAW1033B2 in Obstructive Sleep Apnea (NCT03426631) | Brigham and Women's Hospital | 2017-09-15 |
| Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) (NCT03233204) | National Cancer Institute (NCI) | 2017-09-14 |